Scipher Medicine
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| PREDICT Therapy Selection for JAK, T-cell, or IL-6 Inhibitor Therapies Using a Molecular Signature Response Classifier (PREDICT) (NCT06390709) | Scipher Medicine | 2024-04-08 |
| A Clinical Utility Study of PrismRA for Rheumatoid Arthritis (NCT05161234) | Scipher Medicine | 2022-03-03 |
Track Scipher Medicine automatically
Every clearance here is in the API, with alerts when new ones post.